To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Sverica’s Women’s Health USA enters 2nd round of process
The Boston-based PE firm acquired a majority interest in WHUSA in August 2017, and in 2019 completed the spin-out of In Vitro Sciences into an independent platform investment.
